Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.

Ann Clin Transl Neurol · 2016 · PMC4774261 · PMID 27042677

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < 0.0001actually significant

3 C) and a lower, but still highly significant, decrease in CSF sCD21 levels (maximum decrease with median of −28.02% at Mo 3, P < 0.0001).

also in 132,142 other papers

did not reach statistical significanceno p-value reported

However, the level of ADCC was overall mild and did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.